IBD study tracks 54,000 patients, links dysplasia grade to cancer risk

Precancerous colorectal lesions, or dysplasia, in patients with inflammatory bowel disease (IBD) confer markedly different risks of future colorectal cancer depending on dysplasia grade, according to a comprehensive registry study from Karolinska Institutet, Sweden, and NYU Grossman School of Medicine, New York, published in Clinical Gastroenterology and Hepatology.